(Advisory Board members are in alphabetical order)
Dr Amdekar is a Senior Anaesthetics Registrar at University College Hospital and is an NHS Clinical Entrepreneur Fellow. She is the Medical Director of Oxford Immune Algorithmics. She is interested in cancer anaesthesia and peri-operative medicine. Dr Amdekar has undertaken speciality training at Cancer centres, including The Royal Marsden Hospital, MacMillan Cancer Centre. She is an advanced trainee at Royal National ENT hospital specialising in complex airway. She is a board-certified anaesthetist from The Royal College of Anaesthetists. She graduated from Guy’s, King’s and St. Thomas School of Medine with an Intercalated BSc in Physiology, and completed a research elective at Beth Israel Deaconess Centre, Boston. She has worked closely with various NHS innovation teams and is interested in how biotechnology, AI engineering and digital communications can transform healthcare pathways and patient engagement.
Dr Anthony Bradlow is a specialist in rheumatology and general internal medicine now retired from clinical practice after 37 years as a consultant at the Royal Berkshire NHS Foundation Trust. With Dr Weizi (Vicky) Li at Henley Business School he continues as a researcher into clinical applications of machine learning, point of care blood testing and other aspects of the use of information and data management technology to increase the efficiency of clinical practice. He continues also to work as a medical appraiser, mentor and teacher of medical students at the Royal Berkshire NHS Foundation Trust.
Dr Antoni T.Y. Chan is Consultant Rheumatologist and Physician at the Royal Berkshire NHS Foundation Trust in Reading, United Kingdom. He did his postgraduate training at the University of Oxford where he obtained his PhD in immunology. He is also Associate Medical Director in his hospital. He has led the Outpatient Transformation in the Berkshire West Integrated Care Partnership with a strong digital focus. He successfully implemented the use of remote monitoring of blood tests across multi-specialties, collection of electronic patient reported outcome measures (e-PROM), patient management systems and bed view through data analytics from the electronic patient record, virtual clinics, telemedicine and virtual ward in his hospital and the wider healthcare system. The digital foundations started in 2017 and proved to be extremely valuable for digital readiness during the COVID-19 pandemic in 2020. His work was acknowledged by NHS England in the recently published Rheumatology Digital Playbook. He is a Visiting Fellow at the Henley Business School, University of Reading and a member of the Advisory Board for Blood+ Network.
Emma Glass is the University Partnerships Manager for Healthcare Technologies in the Knowledge Solutions division. She is responsible for engaging with universities in healthcare technology research and innovation to promote participation and raise awareness of standards and standards development. Recent work has included presenting to University of Nottingham’s Centre for Healthcare Technologies and co-creating education resources with the University of Strathclyde. Prior to working at BSI, Emma launched new open-access science journals in digital health, nuclear medicine, oral health and radiology. She also authored CBP’s Big Data Focus Report in 2016 and 2017. Emma has a degree in English Literature from the University of Exeter.
Dimitris Grammatopoulos, PhD, FRCPath, is Professor of Molecular Medicine at Warwick Medical School and Consultant in Clinical Biochemistry and Molecular Diagnostics at the University Hospitals of Coventry and Warwickshire, NHS Trust, United Kingdom. He also leads the Novel Biomarkers theme of the Institute of Precision Diagnostics and Translational Medicine, Pathology-UHCW NHS Trust. where he combines clinical expertise in diagnostic laboratory medicine with a research track-record in application of cutting edge multidiscipline methodologies in routine clinical diagnostics. He received academic and clinical training in Newcastle, Bristol, Johns Hopkins-Baltimore and Warwick. He has expertise in biochemical/molecular diagnosis of many endocrine and metabolic disorders. His translational research interest is focused on stress hormones and homeostatic adaptations of fetal development to maternal disease as well as development of novel -omics based biomarker approaches suitable for precision medicine and better characterisation of patient phenotype. He has experience around use of AI and ML for development and refinement of clinical and diagnostic pathways for complex chronic conditions that are considered as national priorities. Dimitris is the Lead in Diagnostics, Global Health Priorities in Health, University of Warwick.
Dr. Kendall Ho, MD FRCPC FCAHS MGC, is an emergency medical specialist, a professor in the UBC Faculty of Medicine Department of Emergency Medicine, and leads the Digital Emergency Medicine Unit (https://digem.med.ubc.ca/). He is the medical director of BC Ministry of Health Healthlink BC virtual physician program. He conducts digital health research in home health monitoring, data analytics, virtual care, and raising digital health literacy. He is the executive director of the inter-Cultural Online health Network (www.iconproject.org), a non-profit and award winning program sponsored by BC Ministry of Health to support the Multicultural community members to optimize their self-management of chronic diseases through multi-channel engagement. He is a member of the Health Canada Scientific Advisory Committee on Digital Health Technologies, National Research Council Medical Devices Research Advisory Council. He chairs the Canadian Association of Emergency Medicine Digital Emergency Medicine Committee, is a member of the Canadian Virtual Care Task Force, the International Medical Informatics Association Telehealth Working Group, and the International Federation of Emergency Medicine Novel and Advanced Technologies Special Interest Group. Dr. Ho’s body of digital health work has been recognized with provincial and national awards.
Peter is a specialist in measuring healthy aging using high dimensional data, especially genomics. Previously a tenured academic at the University of Edinburgh, and remains an Honorary fellow there. He is now is Chief Scientist at Humanity, an innovative start-up, who are developing sophisticated methods to measure and manage customers rate of aging, using digital and blood biomarkers.
Arjun Panesar is the founder of DDM Health, providers of clinically-validated digital health solutions to over 1.8 million people. Benefiting from almost two decades of experience in big data, AI and AI ethics, Arjun leads the development of evidence-based digital innovations that harness the power of machine learning to provide precision medicine to patients, health services, and governments. Arjun’s work has received international recognition featuring in the Forbes, New Scientist, BBC and The Times. Arjun is a best-selling author on the topics of healthcare and AI, authoring two editions of Machine Learning and AI in Healthcare, and contributing to Handbook of Global Health, a major reference work. Arjun is an advisor to the Information School, University of Sheffield, Fellow to the NHS Innovation Accelerator, visiting lecturer at University of Warwick Medical School, and was recognised by Imperial College as an Alumni Leader for his contribution and impact to society.
Chris Phillips is Senior Vice President of Partnerships at Sensyne Health, a clinical artificial intelligence company focused on improving patient care and medical research. In this role Chris has set and developed the International data strategy for Sensyne working with healthcare systems across the globe. Previous work experience has involved 10 years in Pharma for Novo Nordisk and IQVIA in Market Access and roles as Managing Director for business units in Capita. Chris has a varied background in Strategic Marketing, Business Development, Mergers & Acquisitions, Private Healthcare Services and Public Affairs having worked previously for Alliance Healthcare and Nuffield. Chris originally trained as a Pharmacist in London and has an MBA from Nottingham University Business School.
Kourosh Saeb-Parsy is Professor of Transplantation at the university of Cambridge and Consultant abdominal transplant surgeon at Cambridge University Hospitals NHS Trust. His research is focused on the mechanisms and therapies of ischaemia-reperfusion injury in transplantation, efficacy and immunogenicity of regenerative cellular therapies and immunotherapies. He has established and leads a number of initiatives to support collaborative research between clinical ,academic and commercial organisations, including the Cambridge Biorepository for Translational Medicine and the Cambridge In Vivo Assessment Platform. He is Chief Medical Officer at Oxford Immune Algorithmics, which is focused on longitudinal monitoring of the immune system using AI and ML.
Jurgen is a theoretical physicist, AI researcher and expert in data analytics and machine learning with more than 25 years of industry experience in 3 continents. He created analytics platforms to manage assets of more than $2B in private & investment banking, and held positions in large international companies including UBS, Citibank, Rabobank, Volkswagen, Eon, and more.
Prof. Kelvin Tsoi is a Digital Epidemiologist, currently serving in both School of Public Health and Primary Care and Big Data Decision Analytics Research Centre under The Chinese University of Hong Kong. His research interests focus on digital innovation in chronic disease management, including mobile and telecare application for hypertension management, technological implementation and social engagement for cognitive screening, artificial intelligent application on electronic health records. He also works as the traditional epidemiologist on evidence-based medicine and population cohort studies. Prof. Tsoi is the President of The International Society for Digital Health (ISDH) since 2019. It aims to encourage interdisciplinary research with innovative technology between medicine and engineering. The Society has organized annual symposium in connecting experts from different sectors in the world and to promote digital health. His project entitled “Dementia Screening in 3 Seconds with 1 Simple Drawing” has recently won a Bronze Medal at the 2021 Special Edition of the Geneva International Exhibition of Inventions.
Prof John Williams holds a BA in Physics from Oxford University, a MS in Physics from UCLA, and a Ph.D. in Numerical Methods from University of Wales, Swansea. His research focuses on the application of large-scale computation to problems in cyber-physical security and energy. He is director of MIT’s Geospatial Data Center and from 2006-2012, was Director of the MIT Auto-ID Laboratory, where the Internet of Things was invented. He is author or co-author of over 250 journal and conference papers, as well as the books on Rock Mechanics and RFID Technology. He contributed to the 2013 report for the UK Office for Science Foresight Project- The Future of Manufacturing. Alongside Bill Gates and Larry Ellison, he was named as one of the 50 most powerful people in Computer Networks. He consults to companies including Accenture, Schlumberger, Shell, Total, Exxon, SAP Research, Microsoft Research, Kajima Corp, US Lincoln Laboratory, Sandia National Laboratories, US Intelligence Advanced Research Projects Activity, Motorola, Phillip-Morris Inc., Ford Motor Company, Exxon-Mobil, Shell, Total, and ARAMCO. His international collaborations include Oxford and Cambridge Universities, HKUST, KACST, Alfaisal University, PolyU Hong Kong, Imperial College of Science and Technology UK, Malaysia University of Science and Technology (MUST), and Masdar Institute of Science and Technology Abu Dhabi. He organized the first Cyber-Physical Security Conference in the UK (2011) and along with Dr. Sanchez, he runs the MIT Applied Cyber Security Professional Education summer course. At MIT he teaches courses Architecting Software Systems (MIT 1.125) and Engineering Computation and Data Science (MIT 1.00/1.001).
Dr Philip Wu is a Senior Lecturer (Associate Professor) in Information Management in the School of Business and Management at Royal Holloway, University of London. Prior to gaining his PhD from the iSchool at University of Maryland (USA), he was an instructional technology designer for MetLife, responsible for creating computer-based training systems for new employees. His research lies at the intersection of technology design and human behavior in technology-mediated settings. He has worked with a number of SMEs to co-develop and evaluate digital solutions for various user groups. In recent years, his work has focused on virtual health communities, online reviews, and information privacy.
PhD in Comp Sci (Lille), PhD in Epistemology (Paris, Sorbonne) with 20+ years experience in 6 countries. An elected member of the London Mathematical Society and member of the Canadian College of Health Leaders (CCHL), as a Senior Researcher and faculty member in the Department of Computer Science, University of Oxford, he has published over 100 papers and a dozen of books, including A Computable Universe with a foreword by Sir Roger Penrose (Nobel Prize in Physics, 2020). In 2021, he was appointed Senior Researcher by the Alan Turing Institute at the British Library in London to advise the UK and allies on the future of Artificial Intelligence for scientific discovery, a position funded by the U.S. Department of Defense. In his capacity as policy advisor he has led discussions on the global stage, under the auspices of organisations such as the OECD. After joining the Unit of Computational Medicine as an Assistant Professor he became the leader of the Algorithmic Dynamics Lab at the Karolinska Institute (the institution that awards the Nobel Prize in Physiology or Medicine), also affiliated with SciLifeLab and the Karolinska Hospital in Stockholm, Sweden. He was a NASA Payload team member at MIT in Boston MA for the Mars Gravity Biosatellite to test the health effects of artificial microgravity on mammals. He helped develop the factual answering AI engine behind Siri and Alexa, reporting to Wolfram Research’s CEO, Stephen Wolfram in Champaign, IL. He has been featured in Wired, the New York Times, Le Monde, Scientific American, New Scientist, The Independent, and the MIT Technology Review, among other media venues.